JOSACINE 250 mg/5 ml, granules for oral suspension bottle, 15 g
Active ingredients: Josamycin propionate, Josamycin
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 15 gorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- JOSACINE 250 mg/5 ml, granulés pour suspension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 15 g avec seringue pour administration orale
- Marketing authorisation holder
- ASTELLAS PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 22 Dec 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66113600CIP73230700CIP133400932307005Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| JOSAMYCINE (PROPIONATE DE)granulés | — | SA |
| JOSAMYCINE BASEgranulés | 250 mg · 5 ml de suspension reconstituée | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.